Implementing take-home naloxone in an urban community pharmacy Joshua L. Akers, Ryan N. Hansen, Ryan D. Oftebro Journal of the American Pharmacists Association Volume 57, Issue 2, Pages S161-S167 (March 2017) DOI: 10.1016/j.japh.2017.01.006 Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 1 General pharmacy workflow and staff responsibilities for patient overdose response training. Journal of the American Pharmacists Association 2017 57, S161-S167DOI: (10.1016/j.japh.2017.01.006) Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 2 Patient demographics of available take-home naloxone programs in King County, WA (August 2014). Journal of the American Pharmacists Association 2017 57, S161-S167DOI: (10.1016/j.japh.2017.01.006) Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 3 Take-home naloxone programs in Washington State from 2012 to 2016. Journal of the American Pharmacists Association 2017 57, S161-S167DOI: (10.1016/j.japh.2017.01.006) Copyright © 2017 American Pharmacists Association® Terms and Conditions
Figure 4 Drugs identified in drug-caused deaths, King County, WA. Journal of the American Pharmacists Association 2017 57, S161-S167DOI: (10.1016/j.japh.2017.01.006) Copyright © 2017 American Pharmacists Association® Terms and Conditions